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Abstract 
Background 
Comparable epidemiological data on musculoskeletal impairments (MSI) is lacking. This 
study aimed to estimate the prevalence and causes of MSI in Telangana State, India.  
Method 
A population-based survey used probability proportionate to size and compact segment 
sampling to select fifty-one clusters of 80 individuals (all ages). Participants were screened 
using seven questions and any participant who screened positive underwent standardised 
examination by a physiotherapist for MSI presence, severity and diagnosis. Data were also 
collected on vision and hearing impairment, depression and self-reported difficulties with 
physical functioning. 
Results  
The prevalence of MSI was 19.6% (95%CI: 16.7 - 22.8%) and this increased with age. The 
majority (81%) of MSI was classified as mild, 11% as moderate and 7% as severe. Over half 
(57%) of MSI diagnoses were acquired non-traumatic causes, with degenerative joint 
disease being the most common. There was a high unmet need for physiotherapy services 
(3% attended vs 40% recommended). One fifth (21%) of MSI cases also had at least one of 
vision (10%) or hearing (11%) impairment or depression (3%) 
Conclusions 
MSI is common among persons living in Mahabubnagar District, particularly older adults. 
These estimates can inform public health initiatives for the planning of health and 
rehabilitation services.   
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Introduction 
Musculoskeletal impairments (MSI) are a diverse group of conditions that can affect muscles, 
bones and joints, and are the leading contributor to global years lived with disability (1). It is 
well recognised that persons with disabilities are more likely to be exposed to determinants 
of poor health such as poverty, unemployment (2), social exclusion (3) and discrimination (4) 
compared to the rest of the population. Interventions are therefore needed both to treat MSI 
as well as to improve participation of people with MSI. Accurate data are needed to inform 
appropriate interventions and services (5), however measurement of functioning and 
disability has been limited by lack of consistent definitions and survey tools (4), particularly 
with respect to MSI.  
Assessing disability through self-reported functional limitations, as is used in the Washington 
Group (WG) Questions, is rapid and low cost. However, these methods are not designed to 
estimate the total number of people with disabilities who could benefit from specific health or 
rehabilitation interventions (5). Surveys using objective standardized clinical screening 
criteria to generate reliable and comparable estimates of prevalence, cause and severity of 
MSI are lacking because they rely on trained clinical specialists for assessment (6). These 
data are needed to understand and address the health and rehabilitation service needs of 
persons with MSI. The Rapid Assessment of Musculoskeletal Impairment (RAM) (6) is such a 
clinical screening tool developed to estimate prevalence and causes of MSI. Using a two 
step-process it includes screening questions to assess self-reported difficulties with the 
musculoskeletal system followed by a clinician-led examination. This survey tool has been 
used in surveys in Rwanda (7) and Cameroon (8),however, to date, such surveys have not 
been conducted in Asia and data on MSI is lacking in India.  
Information is also lacking on the extent to which people with MSI also experience other 
impairments (e.g. hearing or vision). This information may be important to inform the 
planning of accessible and inclusive health and rehabilitation services. Another key gap is 
that the relationship between self-reported limitations in physical functioning (e.g. reported 
level of difficulty walking), which are relatively widely available, and the fewer data that report 
clinically assessed MSI is not well understood. Understanding this is important for informing 
and interpreting data from different assessment approaches in population surveys.  
This study aims to estimate the prevalence and causes of MSI in Telangana State, India, 
through an all aged population-based survey. We also explore the relationship between self-
reported functional limitations and clinically assessed MSI and between MSI and other 
impairments.  
Materials and Methods 
Survey population and sampling 
This study was undertaken in Mahabubnagar District, Telangana State in 2014 as part of a 
survey on disability that also collected data on vision, hearing and musculoskeletal 
impairment, depression and self-reported functional limitations (9). The required sample size 
was calculated to be 4,056 based on an expected MSI prevalence of 4% (7, 10), precision of 
20%, 95% confidence, a design effect of 1.5 and 20% non-response.  
We used the 2011 census data for the sampling frame. A two-stage sampling procedure was 
used. First, 51 clusters of 80 individuals (all ages) were selected using probability 
proportionate to size sampling. Second, within clusters, households were selected through 
compact segment sampling. Maps were divided into segments of approximately 80 people 
and one segment was randomly selected. The enumerators visited all households 
sequentially in that segment until 80 people were included (although for logistical reasons, 
4,125 people were enumerated). 
Demographic details recorded included the name, age, sex and contact details of each 
household member. Household members were informed about the survey and invited to 
attend a clinic at a central location over the following two days. If an eligible person did not 
attend, the enumerators visited their home at least twice to encourage attendance. The 
survey team visited any eligible person who was unable to travel (e.g. due to mobility 
impairment) at their home at the end of the second day. 
Screening for musculoskeletal impairment 
The RAM survey was used to identify persons with mild, moderate or severe MSI that impact 
functioning (6). The RAM methodology comprises a two-stage approach: a self-reported 
screening tool followed by clinical assessment. The original RAM included 5 initial screening 
questions to assess MSI: a) difficulty using the musculoskeletal system (3 items), b) use of 
mobility aids (1 item) and c) whether the participant considered any body part to be missing 
or misshapen (1 item). We added an additional question on chronic back pain based on our 
experience in a previous study, which indicated the screening questions were not picking up 
people experiencing long-term debilitating back pain (8). 
A physiotherapist examined any participant with a positive response to at least one screening 
question. The examination included a standardised observation of activities to assess 
functioning (e.g. walking, putting on a jacket) and examination of the affected area. 
Diagnoses categories for MSI included congenital, traumatic, infective, neurological, or 
acquired non-traumatic non-infective. The physiotherapist assigned a specific diagnosis 
within these categories with a maximum of two diagnoses per case. Aetiology was recorded 
where the timing and cause of the impairment was known. Based on these interviews and 
examinations, the participant was categorised by the physiotherapist as having mild, 
moderate or severe MSI in respect to the musculoskeletal system’s ability to function. Lastly, 
participants were asked about treatment or rehabilitation that they had received for their 
impairment and physiotherapists made referral recommendations with consideration to the 
available services. 
Screening for vision, hearing impairment and depression 
Visual acuity (VA) was assessed using a tumbling ‘E’ chart with 6/18 and 6/60 size optotypes 
for participants aged >5 years. Vision Impairment was defined as presenting VA < 6/18 in the 
better eye. For children aged <2 years, vision was assessed using the fix and follow method. 
For children aged 2-4 years, the child was asked to count or copy the number of fingers held 
up by a vision screener at 6 meters. Children who failed these tests were classified as having 
vision impairment.  
Initial hearing screening was conducted through an otoacoustic emissions (OAE) hearing 
test. Participants who failed this test in both ears or for whom an OAE reading could not be 
taken underwent Pure Tone Audiometry (PTA) screening. Hearing was measured at 1KHz, 2 
KHz, 4 KHz, 0.5KHz and again at 1KHz to ensure consistency of response and the average 
reading for each ear across the 4 frequencies was recorded. Children <4 years underwent 
OAE testing only. Hearing impairment was categorised as >41db (adults aged >18 years) or 
>35db (children ≤18 years).  
Depression was assessed using the Patient Health Questionnaire (PhQ-9) among 
participants aged >17 years only. This tool includes three self-reported screening questions 
with an additional 6 questions asked if the initial screen is positive. Depression was 
categorised as having a score of 20 and above (11). 
Self-reported functional difficulty 
The WG extended set (adult or child version) (12, 13) was used to screen participants for 
self-reported functional limitations. This includes a question on mobility which asks, for 
children: “Compared with children of the same age, does [name] have difficulty walking?” and 
for adults: “Do you have difficulty walking or climbing steps?” These questions are answered 
with a four-point response scale (“no difficulty”, “some difficulty”, “a lot of difficulty” or “cannot 
do at all”). The primary caregiver was interviewed as a proxy for children under the age of 
eight.  
Training 
The survey was undertaken by three teams who underwent seven days of training. Each 
team consisted of two enumerators, two interviewers, one physiotherapist, one ophthalmic 
officer. There was also one ENT doctor who circulated between the three teams. We 
assessed the inter-observer variation for the determination of MSI cause and severity to 
ensure it was of an acceptable standard (i.e. Kappa ≥0.6). 
Data analysis 
Data were analysed using STATA 14.0 (StataCorp LP, College Station, Texas). The cluster 
sampling design was accounted for in the prevalence estimate. We compared clinical 
measures of MSI to self-reported mobility difficulties through estimations of sensitivity, 
specificity and positive and negative predictive values. We estimated two predictive values, 
based on varying definitions of mobility difficulties.  
Ethics 
Ethical Approval was granted by Public Health Foundation of India Institutional Ethics 
Committee, Government of India Health Ministry Screening Committee and The London 
School of Hygiene & Tropical Medicine. Informed written or finger printed consent was 
obtained from all participants. For children <18 years a caregiver was required to provide 
written/finger print consent and to remain present throughout the screening as per national 
requirements. 
  
Results 
4,125 people were enumerated and 3,574 were screened for MSI (response rate 87%). Of 
those who did not participate, 540 (13.1%) were unavailable and 11 (0.3%) refused. The 
majority (82%) of individuals who refused were male. There was a similar distribution of 
males (48%) and females (52%) in the sample. The sample population was similar in terms 
of age and gender distribution to the estimates from the 2011 census for Andhra Pradesh 
(Table 1).  
Table 1 Age and gender distribution of district (census) and study sample population  
 Males Females Total 
Age 
group 
District* 
N (%) 
Study 
sample  
N (%) 
District*  
N (%) 
Study 
sample  
N (%) 
District*  
N (%) 
Study 
sample  
N (%) 
0-9 6,996,285 
(16%) 
365 (21%) 6,592,912 
(17%) 
345 (18%) 13,589,197 
(17%) 
710 (19%) 
10-19 8,405,191 
(19%) 
353 (21%) 7,890,151 
(20%) 
320 (17%) 16,295,342 
(20%) 
673 (19%) 
20-29 7,865,584 
(19%) 
277 (16%) 8,065,546 
(19%) 
356 (19%) 15,931,130 
(19%) 
633 (18%) 
30-39 6,498,919 
(16%) 
214 (13%) 6,592,791 
(15%) 
284 (15%) 13,091,710 
(15%) 
498 (14%) 
40-49 5,169,031 
(12%) 
185 (11%) 4,887,711(12%) 207 (11%) 10,056,742 
(12%) 
392 (11%) 
50-59 3,213,122 
(8%) 
143 (8%) 3,353,862 (8%) 173 (9%) 6,566,984 
(8%) 
316 (9%) 
60-69 2,520,124 
(7%) 
116 (7%) 2,847,567 (6%) 118 (6%) 5,367,691 
(6%) 
234 (7%) 
70-79 1,060,217 
(3%) 
42 (2%) 1,096,130 (3%) 46 (2%) 2,156,347 
(3%) 
88 (2%) 
80+ 
 
325,987 
(1%) 
13 (1%) 428,216 (1%) 17 (1%) 754,203 
(1%) 
30 (1%) 
Total 42,054,460 
(50%) 
1,708 
(48%) 
41,754,886 
(50%) 
1,866 
(52%) 
83,809,346 
(100%) 
3,574 
* Census 2011 data at Andhra Pradesh State Level 
 
Prevalence of MSI 
In total, 699 participants of the 3574 screened were identified as having an MSI, giving an all-
age prevalence of 19.6% (95% CI: 16.7–22.8%) (Table 2). The prevalence of MSI was higher 
among women (21.8%, 18.5–25.5%) than among men (17.1%, 14.2–20.4%). Prevalence of 
MSI increased dramatically with age, from approximately 3% in children and younger adults 
to 51.9% of adults over 50 years (95% CI: 44.7–59.1%). Just over 80% of MSI cases were 
classified as mild (prevalence: 16.1%; 95% CI 13.3–19.2%), and the remainder were 
moderate MSI (prevalence 2.2%; 95% CI 1.8–2.8%) or severe (1.3%; 0.9–1.8%) (Table 2). 
Table 2- Prevalence of MSI by age, gender and impairment severity 
 
 
 
 
 Total 0-17 years 18 – 49 years 50+ years Male Female 
  N % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI) N % (95% CI) 
Any MSI 699 19.6 (16.7 – 22.8) 36 2.9 (2.0 - 4.4) 316 18.8 (15.0 – 23.3) 347 51.9 (44.7 – 59.1) 292 17.1 (14.2 – 20.4) 407 21.8 (18.5 – 25.5) 
Mild 574 16.1 (13.3 – 19.2) 18 1.5 (0.8 0 2.6) 292 17.4 (13.8 – 21.7) 264 39.5 (32.8 – 46.7) 229 13.4 (10.7 – 16.6) 345 18.5 (15.3 – 22.2) 
Moderate 80 2.2 (1.8-2.8) 11 0.9 (0.5-1.6) 16 1.0 (0.6-1.5) 53 7.9 (5.8-10.7) 41 2.4 (1.8-3.2) 39 2.1 (1.5-2.9) 
Severe 45 1.3 (0.9-1.8) 7 0.6 (0.3-1.2) 8 0.5 (0.2-1.0) 30 4.5 (2.9-6.9) 22 1.3 (0.8-2.1) 23 1.2 (0.7-1.9) 
Extrapolating these findings, we estimate that there are a total of 196 000 (95% CI: 167 000–
228 000) people per million population with an MSI in this setting; 10 730 (95% CI: 7400–16 
300) children aged 0–17 years, 88 400 (95% CI: 70 500–11 000) adults aged 18–50 years 
and 83 000 (95% CI: 72 000–95 000) adults >50 years. 
 
Age of impairment 
Among children with MSI, 33% were born with their condition and 25% acquired the 
impairment before they were 5 years. Among adults aged 18–50 years with MSI, the majority 
(65%) acquired their impairment during their adult years (i.e.>17 years) and only 2% were 
born with the impairment. Among adults aged>50 years, 95% developed their impairment 
after the age of 40 years. 
Diagnoses 
There were a total of 741 diagnoses for 699 participants with MSI (Table 3). Of the 741 MSI 
diagnosis just over half (n=424, 57%) were acquired non-traumatic causes, with 
degenerative joint disease being the most common individual diagnosis. Nearly one-third 
(n=235, 32%) of MSI diagnoses were acquired trauma, 9% (n=63) were neurological, 2% 
(n=12) were due to infection and 1% (n=7) was congenital. 
Table 3. MSI diagnoses in survey and extrapolated to total population of India 
Diagnosis Number Total in 
category  
N (%) 
Extrapolated total number of diagnostic 
category to nearest 1,000 (95%CI) 
A. Congenital   7 (1%) 2,198,000 (1,803,000-2,657,000) 
Polydactyly 1    
Congenital hand deformity 1    
Congenital absence of all/part of 
upper limb 
2    
Congenital abnormality of upper limb 1    
Cleft lip 2    
B. Infection   12 (2%) 4,395,000 (3,605,000-5,318,000) 
Joint Infection 8    
n/soft tissue infection/wound 4    
C. Acquired traumatic   235 (32%) 70,319 (57,683,000-85,087,000) 
Burn contracture 5    
Fracture non union 2    
Fracture malunion 29    
Spinal/head Injury 9    
Post traumatic joint stiffness 8    
Muscle problem 167    
Peripheral nerve problem 3    
Amputation 7    
Other 5    
D. Neurological   63 (9%) 19,778,000 (16,223,000-23,931,000) 
Epilepsy 17    
Developmental delay 2    
Cerebral palsy 5    
Paraplegia 3    
Hemiplegia 6    
Quadriplegia 1    
Polio 14    
Other neurological 15    
E. Acquired non-traumatic   424 (57%) 125,257,000 (102,747,000-151,561,000) 
Degenerative joint disease 291    
Non-infective non traumatic joint 
disease 
9    
Bow legs 3    
Knock knees 1    
Spinal pain limiting spine function 55    
TB/spine infection 1    
Limb pain limiting function 36    
Other acquired non-traumatic  28    
Total diagnoses   741  221, 947,000 (182,061,000-268,556,000) 
Diagnoses varied by age (Figure 1). The prevalence of neurological diagnoses was similar in 
all age groups (Table 3). There was a proportional increase in trauma related MSI with age 
from 1% among 0–17 years, 7% among 17–49 years and 15% the >50 years age group. The 
proportion of acquired non-traumatic diagnoses also increased substantially with age so that 
35% among people aged>50 years were acquired non-traumatic. 
 
Figure 1. Prevalence and diagnostic categories of MSI by age group 
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Aetiology   
Of the 699 participants with MSI two-thirds (n=450, 64%) was attributed to ageing (n=140, 
20%) or work/lifestyle (n=310, 44%), 12% (n=84) was due to trauma (road traffic accidents, 
n=36; violence, n=9; self-harm, n=3; and other, n=36), and 4% (n=25) to congenital 
conditions. Other rarer aetiologies included genetic (n=9, 1%), infection (n=21, 3%), 
developmental (n=14, 2%) and iatrogenic (n=2, 0.3%). 
 
Among the 36 children, the majority of MSI included congenital (n=12, 33%), other accidents 
(n=7, 19%) and developmental (n=6, 17%). Among 316 adults aged 18–49 the leading 
aetiology was work/lifestyle (n=215, 68%) and among the 347 older adults (>50 years), 40% 
(n=139), was attributed to ageing and 32% (n=111) to work/lifestyle. 
 
Previous treatment 
The most commonly reported previous treatment or intervention received among people with 
MSI was medication (64%) followed by surgery (4%), mobility aids (3%) and physiotherapy 
(3%) (Table 4). Overall, 13% of people with MSI reported they had not previously received 
any medical or rehabilitation services for their condition.  
Table 4 Treatment for individuals with musculoskeletal impairment 
 
Treatment 
previously 
received 
Treatment 
recommended 
 N % N % 
None 91 13% 86 12% 
Medication 449 64% 344 49% 
Plaster/Splintage 1 0% 2 0% 
Physiotherapy 23 3% 281 40% 
Special Seating 0 0% 1 0% 
Mobility aid 21 3% 16 2% 
Orthosis/appliance/ Prosthesis 3 0.4% 4 
 
1% 
Wheelchair 2 0% 2 0% 
Surgery 25 4% 21 3% 
Traditional medicine 16 2% 0 0% 
 
Recommended treatment 
Medical or rehabilitation services were recommended for the majority (88%) of people with 
MSI in the survey. Medication was the most commonly recommended intervention (49%) 
followed by physiotherapy (40%), surgery (3%), and mobility aids (2%).  
The primary reason given by participants for not seeking further treatment for MSI was 
inability to afford treatment (41%), whilst 20% felt treatment was not necessary because of 
adequate function and 15% felt treatment wasn’t needed because of the older age.   
Other impairments 
Among the 699 participants identified with a MSI, 10% (70/699) had a moderate/severe 
vision impairment, 11% (77/699) had a moderate/severe hearing impairment and 3% 
(21/699) moderate or worse depression. A total of 21% (147/699) of people with a MSI also 
had at least one other impairment (hearing, vision, depression). This varied by age, with 8% 
children <18 years, 4% adults 18–49 years and 36% of adults>50 experiencing at least one 
other impairment. Restricting to those with moderate or severe MSI, 20% had vision 
impairment, 26% had hearing impairment, 13% were classified as having depression and 
overall 43% had at least one other impairment. Existence of other impairments was most 
common among older adults (60%). 
 
Comparison of clinically measured MSI and self-reported difficulties with mobility 
Of the 694 people with clinically assessed MSI (mild, moderate or severe) and WG 
responses in the domain of “walking/climbing”, 447 reported ‘some’ or ‘more’ problem with 
mobility (sensitivity = 64%) using the WG questionnaire (Table 5).  
Table 5: Relationship between clinically assessed impairment and self-reported difficulties 
with mobility 
 Self-reported difficulties 
Clinically assessed MSI None N (%) Some N 
(%) 
A lot N (%) Extreme/ Cannot do 
N (%) 
No MSI  2,459 (90%) 274 (10%) 8 (1%) 0 
Mild  227 (40%) 307 (54%) 37 (6%) 0 
Moderate  16 (20%) 19 (24%) 39 (49%) 6 (8%) 
Severe   4 (9%) 8 (19%) 23 (53%) 8 (19%) 
Any MSI*  247 (36%) 334 (48%) 99 (14%) 14 (2%) 
*NB: WG data were missing for 19 people  
 
Of the 2,741 people who did not have an MSI according to the clinical assessment, 2,459 
reported no difficulty with mobility (specificity: 90%). Of the 2,712 who reported no difficulty, 
2,459 also had no MSI (negative predictive value: 91%). Among the 729 who reported ‘some’ 
or ‘more’ difficulty, only 447 had a clinically assessed MSI (positive predictive value: 61%). If 
a narrower self-reported definition of ‘a lot of difficulty’ or greater is used, the sensitivity 
decreased to 16%, specificity increased to 100%, and positive and negative predictive values 
were 93% and 83% respectively. 
 
Discussion 
This all age population-based survey found a high prevalence of MSI in Mahabubnagar 
District India with nearly a fifth of the population affected. The majority (82%) of MSI cases 
were classified as mild, 11% as moderate and 7% as severe. The prevalence of MSI 
increased dramatically with age, from 3% in children to 51% among people aged >50 years. 
This is due to the increase in MSI from acquired non-traumatic causes (particularly 
degenerative joint diseases) and trauma occurring in this older age group. There is a large 
unmet need for rehabilitation and treatment. 
Comparison to previous studies 
There are limited data from India to compare our findings. Our estimates are considerably 
higher than the 2.2% prevalence of all disability estimated in the 2011 census (14). However, 
the census used a single question on self-reported disability (‘Is this person 
mentally/physically disabled?) which is likely to lead to under-reporting of disability because 
of issues around stigma and self-identification of disability (5). The high prevalence of MSI 
among older adults aligns with a previous study in the city of Chandigarh which reported that 
88% of elderly people (aged over 60 years) had minimal to severe disabilities (15). Data on 
MSI epidemiology specifically are lacking, but the high prevalence in our survey concurs with 
a study in southern India which found that 26% of adults (>15 years) reported 
musculoskeletal pain (16). Our prevalence estimates (19.6%) were higher than previous 
surveys using the RAM survey in Rwanda (5.2%)(7) and Cameroon (11.6%) (8), although the 
trend of rapidly increasing prevalence by age and distribution of causes were similar. The 
difference is driven primarily by a higher prevalence of mild MSI in India (16.1%) compared 
to Cameroon (8.2%) and Rwanda (2.4%). The prevalence for moderate/severe MSI in the 
three settings is comparable (India 3.5%, Cameroon 3.4%, Rwanda 2.8%). A reason for this 
may include the higher life expectancy in India (68.5 years versus 58.5 years in Cameroon 
and 60.1 years in Rwanda)(16) or the inclusion of a question on back pain in India, but not in 
the other settings. 
Treatment gap 
Most people with MSI (87%) reported having received some kind of medical or rehabilitation 
services, however, this was most commonly medication (64%), which could include 
painkillers. The proportion that received physiotherapy was very low (3%) and yet this was 
recommended as an intervention for 40% of cases based on clinical examination. This 
treatment gap is similar to previous studies in India that demonstrated few persons with 
disabilities benefit from rehabilitation services (17) and providing rehabilitation services to the 
unreached persons with disabilities living in rural areas and small towns is a challenge (18). 
The finding in our study that cost was the leading reason for not seeking services, aligns with 
research in Uttar Pradesh and Tamil Nadu states of India (19). These studies also found lack 
of services and transportation were key barriers to using health facilities. Additionally, there is 
a need to think beyond the provision of rehabilitation toward holistic inclusion of persons with 
disabilities. Participation of persons with disabilities may be encouraged through community-
based rehabilitation (CBR) programmes in rural communities. For example, a three-year 
project in a disadvantaged community near Allahabad, India, resulted in many children with 
disabilities attending school for the first time, and more carers bringing their children with 
disabilities for vaccination and rehabilitation (20).  
Relationship between clinically assessed and self-reported MSI 
Previous surveys typically either assessed only self-reported limitations in physical 
functioning (e.g. difficulty with walking) or, a few, conduct clinical assessment of MSI. In this 
study we collected data using both approaches, which allowed us to explore the overlap 
between the populations identified by the two methods. Using self-report of ‘some’ or ‘more’ 
difficulty' with walking/climbing would result in 36% of mild or worse MSI not being identified. 
Using the narrower category of ‘a lot of difficulty’  (the definition commonly used in surveys 
for classifying people as having a disability (5) would miss 39% of the clinically confirmed 
cases with moderate or worse MSI or 86% with mild or worse MSI. Further, 61% of those 
who self-reported ‘some’ or ‘more’ difficulty were not classified as having an impairment. The 
discrepancies in population identified suggests that the two measurement approaches 
capture different aspects of disability. The RAM method uses self-report functioning 
questions to screen in the first stage and asks a greater number of specific questions on 
body function, as well as whether any body parts are considered misshapen. The WG 
questions focus on walking/climbing only and this may explain the difference. Using clinical 
assessment and self-report together in disability surveys may be helpful to identify the 
majority of people with disability (5), although a focus on clinical assessment may be optimal 
when planning need for physical rehabilitation services. 
Recommendations 
The data collected in this survey provide useful information to assist planning of rehabilitation 
services for persons with MSI in India, which cannot be produced through self-reported 
functional difficulties alone. This study estimates that 196,000 people per million population 
in India will experience MSI, that degenerative joint diseases are the leading cause and that 
the vast majority could benefit from some kind of medical or rehabilitation intervention. 
Production and supply for equipment (e.g. assistive devices) can be anticipated and the need 
for services such as physiotherapy and surgery as well as equipment can be similarly 
estimated. For example, findings suggest that 44,390,000 people in India could benefit from 
Physiotherapy. This global gap in resources has been recognised by the World Health 
Organisation (WHO) with the Rehabilitation 2030: A Call for Action (21). As provision of 
rehabilitation grows as an international priority in order to meet the Universal Health 
Coverage targets, plans that account for the growth of non-communicable diseases and for 
an ageing population are required. Scale up of rehabilitation services and consideration of 
innovative methods to provide rehabilitation and other services, such as mobile tools for 
home exercise programmes (22) warrant further investigation. In addition, the survey data 
highlight that experiencing multiple impairments is common. This should be taken into 
account when planning services to ensure, for example, that physiotherapy services are fully 
accessible to those with vision or hearing impairments and that appropriate attention and 
support is given to the psychological well-being of people with physical impairments.  
Strengths and limitations  
This was an all-age population based survey that used robust sampling methodology to 
provide estimates of musculoskeletal impairment and rehabilitation needs. There are some 
study limitations. The study relied on a relatively simplified assessment that was conducted 
in the field rather than in clinical settings. Unlike vision or hearing which have objective tests, 
classifying the severity of MSI is in part down to the clinician’s judgement and therefore some 
subjectivity in this assessment is unavoidable. We aimed to standardise this as much as 
possible with thorough training of the physiotherapists.  
Conclusions 
Nearly a fifth of people living in Mahabubnagar District have a musculoskeletal impairment 
and this is estimated to be moderate or severe for 3.5%. Among adults aged 50 years and 
above the prevalence was 51% and this was largely due to degenerative joint diseases. The 
findings suggest there is high unmet need for physiotherapy and other rehabilitation services 
among people with MSI. 
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